These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
971 related articles for article (PubMed ID: 36257316)
1. Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy. Yang F; Xiao Y; Ding JH; Jin X; Ma D; Li DQ; Shi JX; Huang W; Wang YP; Jiang YZ; Shao ZM Cell Metab; 2023 Jan; 35(1):84-100.e8. PubMed ID: 36257316 [TBL] [Abstract][Full Text] [Related]
2. Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor-Positive Triple-Negative Breast Cancer. Li J; Wu Y; Li Y; Zhu H; Zhang Z; Li Y ACS Nano; 2024 Oct; 18(39):26585-26599. PubMed ID: 39287044 [TBL] [Abstract][Full Text] [Related]
3. The Achilles heel of TNBCs: Ferroptosis heterogeneity. Jiang L; Gao XM; Cao J Cell Metab; 2023 Jan; 35(1):1-2. PubMed ID: 36599296 [TBL] [Abstract][Full Text] [Related]
4. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells. Ding Y; Chen X; Liu C; Ge W; Wang Q; Hao X; Wang M; Chen Y; Zhang Q J Hematol Oncol; 2021 Jan; 14(1):19. PubMed ID: 33472669 [TBL] [Abstract][Full Text] [Related]
5. Ferroptosis as a promising targeted therapy for triple negative breast cancer. Mokhtarpour K; Razi S; Rezaei N Breast Cancer Res Treat; 2024 Oct; 207(3):497-513. PubMed ID: 38874688 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism. Li P; Lin Q; Sun S; Yang N; Xia Y; Cao S; Zhang W; Li Q; Guo H; Zhu M; Wang Y; Zheng Z; Li S Cell Death Dis; 2022 Sep; 13(9):808. PubMed ID: 36130940 [TBL] [Abstract][Full Text] [Related]
7. Discovery of Novel Potent Covalent Glutathione Peroxidase 4 Inhibitors as Highly Selective Ferroptosis Inducers for the Treatment of Triple-Negative Breast Cancer. Chen T; Leng J; Tan J; Zhao Y; Xie S; Zhao S; Yan X; Zhu L; Luo J; Kong L; Yin Y J Med Chem; 2023 Jul; 66(14):10036-10059. PubMed ID: 37452764 [TBL] [Abstract][Full Text] [Related]
8. PTGER3 knockdown inhibits the vulnerability of triple-negative breast cancer to ferroptosis. Wang S; Zhang Y; Zhang D; Meng J; Che N; Zhao X; Liu T Cancer Sci; 2024 Jun; 115(6):2067-2081. PubMed ID: 38566528 [TBL] [Abstract][Full Text] [Related]
9. Ferroptosis-enhanced chemotherapy for triple-negative breast cancer with magnetic composite nanoparticles. Zhang J; Zhou K; Lin J; Yao X; Ju D; Zeng X; Pang Z; Yang W Biomaterials; 2023 Dec; 303():122395. PubMed ID: 37988899 [TBL] [Abstract][Full Text] [Related]
10. Anomanolide C suppresses tumor progression and metastasis by ubiquitinating GPX4-driven autophagy-dependent ferroptosis in triple negative breast cancer. Chen YM; Xu W; Liu Y; Zhang JH; Yang YY; Wang ZW; Sun DJ; Li H; Liu B; Chen LX Int J Biol Sci; 2023; 19(8):2531-2550. PubMed ID: 37215985 [TBL] [Abstract][Full Text] [Related]
11. A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapy. Chen Y; Yao Z; Liu P; Hu Q; Huang Y; Ping L; Zhang F; Tang H; Wan T; Ping Y; Li B Acta Biomater; 2023 Mar; 159():275-288. PubMed ID: 36709836 [TBL] [Abstract][Full Text] [Related]
12. Ferroptosis induction via targeting metabolic alterations in triple-negative breast cancer. Wang Y; Sun Y; Wang F; Wang H; Hu J Biomed Pharmacother; 2023 Dec; 169():115866. PubMed ID: 37951026 [TBL] [Abstract][Full Text] [Related]
13. PRMT5 reduces immunotherapy efficacy in triple-negative breast cancer by methylating KEAP1 and inhibiting ferroptosis. Wang Z; Li R; Hou N; Zhang J; Wang T; Fan P; Ji C; Zhang B; Liu L; Wang Y; Kong J; Yao Q; Duan J; Zhao G; Ling R; Zhang J J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37380368 [TBL] [Abstract][Full Text] [Related]
14. Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells. Lei M; Zhang YL; Huang FY; Chen HY; Chen MH; Wu RH; Dai SZ; He GS; Tan GH; Zheng WP Sci Rep; 2023 Dec; 13(1):21916. PubMed ID: 38081931 [TBL] [Abstract][Full Text] [Related]
15. Ultrasound-Targeted Microbubble Disruption with Key Nanodroplets for Effective Ferroptosis in Triple-Negative Breast Cancer Using Animal Model. Liu R; Shi D; Guo L; Xiao S; Shang M; Sun X; Meng D; Zhao Y; Wang X; Li J Int J Nanomedicine; 2023; 18():2037-2052. PubMed ID: 37155504 [TBL] [Abstract][Full Text] [Related]
16. The treatment landscape of triple-negative breast cancer. Hu Y; Wang C; Liang H; Li J; Yang Q Med Oncol; 2024 Aug; 41(10):236. PubMed ID: 39210220 [TBL] [Abstract][Full Text] [Related]
17. Simvastatin induced ferroptosis for triple-negative breast cancer therapy. Yao X; Xie R; Cao Y; Tang J; Men Y; Peng H; Yang W J Nanobiotechnology; 2021 Oct; 19(1):311. PubMed ID: 34627266 [TBL] [Abstract][Full Text] [Related]
18. Simeprevir induces ferroptosis through β-TrCP/Nrf2/GPX4 axis in triple-negative breast cancer cells. Lin Z; Liu Z; Yang X; Pan Z; Feng Y; Zhang Y; Chen H; Lao L; Chen J; Shi F; Gong C; Zeng W Biomed Pharmacother; 2024 Nov; 180():117558. PubMed ID: 39405915 [TBL] [Abstract][Full Text] [Related]
19. PGRMC1 promotes triple-negative breast cancer cell growth via suppressing ferroptosis. Zhao Y; Ruan X; Cheng J; Xu X; Gu M; Mueck AO Climacteric; 2023 Apr; 26(2):135-142. PubMed ID: 36724820 [TBL] [Abstract][Full Text] [Related]
20. High Intensity Focused Ultrasound-Driven Nanomotor for Effective Ferroptosis-Immunotherapy of TNBC. Yu X; Li X; Chen Q; Wang S; Xu R; He Y; Qin X; Zhang J; Yang W; Shi L; Lu L; Zheng Y; Pang Z; Peng S Adv Sci (Weinh); 2024 Apr; 11(15):e2305546. PubMed ID: 38342612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]